Reduction of leukemia cell burden and restoration of normal hematopoiesis at 3 months of crizotinib treatment in RAN-binding protein 2 (RANBP2)–anaplastic lymphoma kinase (ALK) acute myeloid leukemia
Crossref DOI link: https://doi.org/10.1038/leu.2014.166
Published Online: 2014-05-21
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Maesako, Y
Okumura, A
Takeoka, K
Kishimori, C
Izumi, K
Kamoda, Y
Iioka, F
Akasaka, T
Ohno, H
Text and Data Mining valid from 2014-05-21
Version of Record valid from 2014-05-21
Article History
First Online: 21 May 2014
Competing interests
: The authors declare no conflict of interest.